rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-6-26
|
pubmed:abstractText |
Cervical cancer development from a squamous intraepithelial lesion is thought to be favored by an impaired T cell immunity. We evaluated parameters of T cell alterations such as proliferation, cytokine, and CD3zeta expression in peripheral blood and tumor-infiltrating T lymphocytes from women with squamous intraepithelial lesions (SIL) or cervical cancer (CC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD3,
http://linkedlifedata.com/resource/pubmed/chemical/CD3 antigen, zeta chain,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Conditioned,
http://linkedlifedata.com/resource/pubmed/chemical/IL10 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/IL2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Phytohemagglutinins,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1573-2592
|
pubmed:author |
pubmed-author:Alcocer-GonzálezJuan MJM,
pubmed-author:Alonso de RuízPatriciaP,
pubmed-author:Bermúdez-MoralesVictor HVH,
pubmed-author:Díaz-BenítezCinthya ECE,
pubmed-author:Flores-SosaJacqueline AJA,
pubmed-author:González-MenaLudwig ELE,
pubmed-author:Hernández-PandoRogelioR,
pubmed-author:Juárez-DíazJanetJ,
pubmed-author:López-EstradaGuillerminaG,
pubmed-author:Lagunas-MartínezAlfredoA,
pubmed-author:Madrid-MarinaVicenteV,
pubmed-author:Martínez-BarnetcheJesúsJ,
pubmed-author:MorenoJoséJ,
pubmed-author:Navarro-FuentesKarla RKR,
pubmed-author:Román-BasaureEdgarE,
pubmed-author:RosensteinYvonneY,
pubmed-author:Uribe-SalasFelipe JFJ
|
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
532-44
|
pubmed:meshHeading |
pubmed-meshheading:19259799-Adult,
pubmed-meshheading:19259799-Aged,
pubmed-meshheading:19259799-Antigens, CD3,
pubmed-meshheading:19259799-Cell Line, Tumor,
pubmed-meshheading:19259799-Cell Proliferation,
pubmed-meshheading:19259799-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:19259799-Culture Media, Conditioned,
pubmed-meshheading:19259799-Female,
pubmed-meshheading:19259799-HeLa Cells,
pubmed-meshheading:19259799-Humans,
pubmed-meshheading:19259799-Interferon-gamma,
pubmed-meshheading:19259799-Interleukin-10,
pubmed-meshheading:19259799-Interleukin-2,
pubmed-meshheading:19259799-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:19259799-Middle Aged,
pubmed-meshheading:19259799-Phytohemagglutinins,
pubmed-meshheading:19259799-T-Lymphocytes,
pubmed-meshheading:19259799-Transforming Growth Factor beta1,
pubmed-meshheading:19259799-Uterine Cervical Neoplasms
|
pubmed:year |
2009
|
pubmed:articleTitle |
CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.
|
pubmed:affiliation |
División de Infecciones Crónicas y Cáncer, Instituto Nacional de Salud Pública de México, Sta María Ahuacatitlán, 62508 Cuernavaca, Morelos, Mexico.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|